Early data published from a clinical trial show that Stereotactic Body Radiation Therapy (SBRT) can be used as a safe alternative for surgery in patients with early stage lung cancer.
iJAMA Oncology/i recently published data from NRG Oncology's RTOG 0618 trial which shows that the utilization of Stereotactic Body Radiation Therapy (SBRT) as a treatment for medically operable lung cancer is associated with favorable primary tumor control and local control rates.
"The current standard therapy ...
↧